作者：
Javier,Pascual [1]
;
Joline S J,Lim [2]
;
Iain R,Macpherson [3]
;
Anne C,Armstrong [4]
;
Alistair,Ring [5]
;
Alicia F C,Okines [1]
;
Rosalind J,Cutts [1]
;
Maria Teresa,Herrera-Abreu [2]
;
Isaac,Garcia-Murillas [2]
;
Alex,Pearson [2]
;
Sarah,Hrebien [2]
;
Heidrun,Gevensleben [2]
;
Paula Z,Proszek [6]
;
Michael,Hubank [7]
;
Margaret,Hills [7]
;
Jenny,King [8]
;
Mona,Parmar [9]
;
Toby,Prout [9]
;
Laura,Finneran [9]
;
Jason,Malia [9]
;
Karen E,Swales [10]
;
Ruth,Ruddle [10]
;
Florence I,Raynaud [10]
;
Alison,Turner [10]
;
Emma,Hall [9]
;
Timothy A,Yap [9]
;
Juanita S,Lopez [11]
;
Nicholas C,Turner [9]
作者单位：
Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
[1]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
[2]
National University Cancer Institute, Singapore (NCIS), National University Hospital, Singapore.
[3]
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
[4]
Department of Medical Oncology, Christie Hospital NHS Foundation Trust and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
[5]
University Hospital Bonn, Bonn, Germany.
[6]
Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
[7]
Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
[8]
Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
[9]
Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
[10]
Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
[11]
Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom. nick.turner@icr.ac.uk.
[12]
DOI
10.1158/2159-8290.CD-20-0553
PMID
32958578
发布时间
2024-02-10
换一批
换一批
